FineCell MC - Validating a new idea that allows for commercial use of dry Nanocellulose
Reference number | |
Coordinator | FineCell Sweden AB |
Funding from Vinnova | SEK 490 000 |
Project duration | November 2018 - June 2019 |
Status | Completed |
Important results from the project
We’ve met the project’s goals. Goal 1 is to validate the scalability of FineCell’s production technology. In this project, due to successful production trials by using pilot scale equipment, it has been validated that our microcellulose can be made at pilot scale with industrially feasible setups. Goal 2 is to validate the feasibility of using FineCell’s microcellulose as reinforcements for composites. In this project, due to successful compounding trials at our lead’s site, it has been validated that our microcellulose can provide significant reinforcing effects to composites.
Expected long term effects
This project’s result formed the foundation for us to define an industrially and commercially feasible way of producing microcellulose, which has higher value than traditional paper products from Swedish forest resources. It also helped us build viable business cases to refine our current business plan. Upon launching full commercial scale production, our microcellulose will be able to help release our dependence on oil-based products in the material’s sector, and enable us to contribute to UN’s 2030 Agenda for Sustainable Development Goals.
Approach and implementation
For reaching goal 1, we contacted 5 organizations which had the competence and equipment to help us with pilot production trials. Among which, 1 had performed successful trials, which showed that our microcellulose can be made at pilot scale. For reaching goal 2, we contacted several compounders and plastic/composite manufacturers. Among which, 4 have shown solid interests in testing our microcellulose for composite’s reinforcement. 2 of them had performed the tests and the results were promising. 1 of these 2 placed an order to purchase more microcellulose for further tests.